Found 154 matching trials
Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks PHASE3 The purpose of this study is to complete the total safety database size for...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above PHASE3 To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vacc...
Show More Location
Anning First People's Hospital
Learn More & Join Trial
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma PHASE2 Reported in the 2018 NEJM (378; 1277) article, the combination of checkpoin...
Show More Location
Multiple Locations
Learn More & Join Trial
Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers PHASE2 Immune response analysis after the combination of PCV13 and PPV23 will lead...
Show More Location
Multiple Locations
Learn More & Join Trial
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas PHASE1 The purpose of this study is to determine the safety and efficacy of a PEPI...
Show More Location
Duke University Medical Center
Learn More & Join Trial
COVID Protection After Transplant-Immunosuppression Reduction PHASE2 This study will enroll individuals who have:
* Completed primary series of...
Show More Location
University of California, San Diego
Learn More & Join Trial
Diabetes Group Visits N/A This pilot study aims to increase access to diabetes education by deliverin...
Show More Location
Grady North DeKalb Clinic
Learn More & Join Trial
Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants PHASE2 This study will assess the impact on nasopharyngeal carriage, safety and im...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old PHASE4 This is an open-label, randomized and controlled phase Ⅳ clinical trial of ...
Show More Location
Huaiyin Center for Disease Control and Prevention
Learn More & Join Trial
Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years PHASE3 The purpose of this study is to evaluate the immunogenicity and safety of G...
Show More Location
Hunan Center for Disease Control and Prevention
Learn More & Join Trial